1Gisslinger H, Kurzrock R, Wtzler M,et al. Apoptosis in chronic myelogenous leukemia: studies of stage-specific differences.Leuk Lymphoma 1997;25:121
2Daley GO, Ben Neriah Y. Implicating the bcr/ab1 in the pathogenesis of Ph+humanleukemia. Adv Cancer Res 1991;57:151
3Rostiv, Bergamaschi G, Ponchio L, et al. c-ab1 function in normal and chronicmyelogenous leukemia hematopoiesis:in vitro studies with antisense oligomers. Leukemia1992;6:1
4Fialkow JP, Martin PJ, Najfeld V, et al. Evidence for multistep pathogenesis ofchronic myelogenous leukemia. Blood 1981;58:158
5Sram K, Heisterkamp N, Grosveld, et al. Evidence of a new chimneric bcr/ab1 mRNA inpatients with chronic myelogenous leukemia and the Philadelphia chromosome. N Engl J Med1985;313:1429
6Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia inmice by the P210 bcr/ab1 gene of the Philadelphia chromosome. Science 1990;247:824
7Gisslinger H, Kurzrock R, Wetzler M, et al. Apotosis in chronic myelogenousleukemia: studies of stage-specific differences. Leuk Lymphoma 1997;25:121
8De Fabritiis P, Skorski T, De Propris MS, et al. Effect of bcr/ab1oligodeoxynucleotides on the clonogenic growth of chronic myelogenous leukemia cells.Leukemia 1997;11:811
9Preti HA,O'Brien S,Giralt S,et al. Philadelphia chromosome positive adult acutelymphocytic leukemia: characteristics, treatment result, and prognosis in 41 patients. AmJ Med 1994;97:60
10The Group Franais de Cytogenetique Hematologique.Cytogenetic abnormalities inadult acute lymphoblastic leukemia: correlation with hematologic ficings and outcome.Blood 1996;87:3135
4Steer E J, Cross NC. Myeloproliferative disorders with translocation of chromosomes 5q31-35: role of the platelet-derived growth factor receptor beta. Acta Haematol, 2002, 107 :113-122.
5Wittman B, Horan J, Baxter J, et al. A 2-year-old with atypical CML with a t(5 ; 12) ( q33 ; p13 ) treated successfully with imatinib mesylate. Leuk Res, 2004, 28 Suppl 1: 65-69.
6Xin H, Medeiros J, Abruzzo LV, et al. Chronic myeloproliferative diseases with the t(5 ; 12 ) ( q33 ; p13 ). Am J Clin Pathol, 2006, 125 : 49-56.
7Bain BJ. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRa, PDGFRI3or FGFR1. Haematologica, 2010, 95: 696-698.
8Rodig SJ, Kutok JL. Bone marrow disorders with associated eosino- philia. Diagnostic Histopathology, 2009, 15: 107-115.
9Galimberti S, Ferreri MI, Simi P, et al. Platelet-derived growth factor beta receptor (PDGFRβ) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotype. Br J Haematol, 2009, 147: 763-766.
10Golub T, Barker GF, Lovett M, et al. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leu-kemia with t(5 ; 12) chromosomal translocation. Cell, 1994, 77 : 307 -316.
